« Return to News | CROs/Service Providers

PRA acquires ClinStar

Monday, March 4, 2013 10:43 AM

Raleigh, N.C.-based CRO PRA has acquired privately held ClinStar, a CRO managing phase I-IV clinical trials in the Russian Federation, Ukraine, Belarus and the Baltic States.

Russia and Eastern Europe have proven to be very important to the biopharmaceutical industry. The acquisition will  help PRA establish a stronger presence there with one of the region’s well established CROs.

"With ClinStar's high-caliber staff, culture and passion for customer service, it is a logical fit for PRA," said Colin Shannon, president and CEO of PRA. "ClinStar will augment PRA's operations and expertise in Russia and Eastern Europe. Their knowledge and experience in this region complements PRA's overall global reach and infrastructure."

The acquisition also includes ClinStar's standalone clinical trial warehousing and logistics division, IMP Logistics, operating in Russia, Ukraine and Belarus. PRA now can offer cold chain logistics services including importation of investigational products, clinical supplies, laboratory kits and printed materials, storage in multiple temperature zones, distribution to sites, collection of returned medication and coordination of product destruction.

Over the coming months, PRA plans to integrate the 300 ClinStar and IMP Logistics employees. Financial terms of the agreement were not disclosed.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.